CNSI Entrepreneurship Forum
Presented by UCLA Business of Science Center
Tuesday May 26, 4PM @ CNSI Auditorium
Kite Pharma’s Journey from a UCLA Incubator to NASDAQ Listing
Hear about how UCLA faculty co-founders formed Kite Pharma and the factors that led to a successful IPO.
About Kite Pharma
Kite Pharma, founded in 2009, is a clinical stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. Kite Pharma’s goal is to be a leader in immunotherapy in multiple cancer indications. To achieve this, they are developing a pipeline of product candidates for the treatment of advanced solid and hematological malignancies using their therapeutic platform – engineered Autologous Cell Therapy (eACT™) – in which a patient’s own T cells, or white blood cells, are engineered to recognize and destroy their cancer.
About UCLA Business of Science Center
The mission of the UCLA Business of Science Center is to prepare scientific, engineering, law, medical and business graduate students for careers in the private sector; to assist university faculty and clinicians in technology transfer; and to serve as a catalyst for increased industry support and involvement on campus. We believe this will foster a culture of innovation and will maximize the impact of UCLA research on society.
About CNSI Entrepreneurship Forum
CNSI’s Entrepreneurship Forum is designed to enable entrepreneurial UCLA faculty, staff and students to exchange ideas and build relationships across LA’s entrepreneurial ecosystem. The forum serves CNSI’s mission to facilitate commercialization by creating an environment where innovative ideas can be shared and cultivated into commercial opportunities.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly